# DIFLUNISAL
> **ANDA203547** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2017-06-16
## Drug
- **FDA Application Number:** ANDA203547
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DIFLUNISAL
- **Generic name:** DIFLUNISAL
- **Active ingredients:** DIFLUNISAL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ZYDUS PHARMS
- **Manufacturer:** Zydus Pharmaceuticals (USA) Inc.
- **First approval:** 2017-06-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203547)
---
*AI Analytics · CC0 1.0*